Loading company…
Nephronomics applies genomic and clinical data to precision medicine research.
Founded in 2023 and based in Dover, US, Nephronomics focuses on renal, cardiovascular and metabolic diseases. Its Nephronomics Atlas combines whole genome sequencing and longitudinal medical records from over 35,000 patients with end-stage kidney disease. In April 2026, it raised venture funding from CerraCap Ventures.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in